Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 15, 2024 (2 years ago)

OneLAX Docusate Sodium Liquid

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.

Affected NDC 71399-0039-06

Compare with the code on your package — it is the most precise check available.

Drug: Docusate

Recalling firm
Akron Pharma, Inc.
NDC code
71399-0039-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0025-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Docusate recalls

See all
Class II · Moderate risk

Docusate Sodium 250 mg

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Ongoing Packaging defect Safecor Health, LLC NDC 48433-101-01 D-0060-2025
Class II · Moderate risk

Docu Liquid

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0801-2023

Other recalls by Akron Pharma, Inc.

All 2024 recalls
Class III · Low risk

Diphenhydramine HCl 50 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8026-02 D-0199-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-2 D-0198-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-1 D-0197-2025